Latest filing published 23 Aug 2023 for Vera Therapeutics, Inc., €23k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Celia Lin: trading record in brief
Celia Lin is a declared insider of Vera Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 19 August 2022 to 21 August 2023.
Sales make up the whole of the open-market record (1 sale, €23k). Besides market trades, the filings include 1 share grant. 2023 to date brings no purchases and 1 sale.
On 23 August 2023 came the latest disclosure, an open-market sale for €23k in Vera Therapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Celia Lin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,490 shares@ US$16.6547100.0% of flowClass A Common StockSEC:0001209191-23-047105:0
- 12,500 shares0Class A Common StockSEC:0001209191-22-047170:0
2 of 2 declarations
